SGH Capital deploys capital in early and mid-stage disruptive companies across the US and Western Europe. They invest in direct equity, venture debt, and fund-of-funds, targeting both emerging and established teams. A key differentiator is their use of a proprietary AI platform, developed by a global community of scientists, to make precise capital allocations, ensuring investments in the right companies and funds at the right time. The firm has completed over 200 investments with a stated 70% success factor, spanning from Seed to Pre-IPO stages, across diverse verticals. Their investment approach spans a broad range of sectors, including Food Tech, Advanced AI-powered Robotics, and more. This suggests a generalist approach within the technology and innovation landscape, actively seeking disruptive opportunities across various industries. They seem to have a focus on North America, however, do invest in the US and Western Europe. SGH's strategy is based on leveraging advanced data analytics and a broad network of scientific expertise to identify promising ventures. This 'quantamental' approach, as described by Alexandre Azoulay, combines quantitative data analysis with fundamental qualitative research, aiming to enhance the precision and effectiveness of their investment decisions. This scientific approach is a very unique advantage within the VC space.
Preferred startup development maturity for initial funding deployment.
Marketplace / B2C, X-tech / Robotics, Logistics, Health / Beauty, Funds, Food, civic / media, Enterprise / SaaS, fintech-blockchain
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...